Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes
- PMID: 17168782
- DOI: 10.2174/138920306779025611
Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes
Abstract
Cancer is a major cause of premature death and there is an urgent need for new anticancer agents with novel mechanisms of action. Here we review recent studies on a group of peptides that show much promise in this regard, exemplified by arthropod cecropins and amphibian magainins and aureins. These molecules are alpha-helical defence peptides, which show potent anticancer activity (alpha-ACPs) in addition to their established roles as antimicrobial factors and modulators of innate immune systems. Generally, alpha-ACPs exhibit selectivity for cancer and microbial cells primarily due to their elevated levels of negative membrane surface charge as compared to non-cancerous eukaryotic cells. The anticancer activity of alpha-ACPs normally occurs at micromolar levels but is not accompanied by significant levels of haemolysis or toxicity to other mammalian cells. Structure/function studies have established that architectural features of alpha-ACPs such as amphiphilicty levels and hydrophobic arc size are of major importance to the ability of these peptides to invade cancer cell membranes. In the vast majority of cases the mechanisms underlying such killing involves disruption of mitochondrial membrane integrity and/or that of the plasma membrane of the target tumour cells. Moreover, these mechanisms do not appear to proceed via receptor-mediated routes but are thought to be effected in most cases by the carpet/toroidal pore model and variants. Usually, these membrane interactions lead to loss of membrane integrity and cell death utilising apoptic and necrotic pathways. It is concluded that that alpha-ACPs are major contenders in the search for new anticancer drugs, underlined by the fact that a number of these peptides have been patented in this capacity.
Similar articles
-
Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.Mini Rev Med Chem. 2015;15(1):73-81. doi: 10.2174/1389557514666141107120954. Mini Rev Med Chem. 2015. PMID: 25382016 Review.
-
On the selectivity and efficacy of defense peptides with respect to cancer cells.Med Res Rev. 2013 Jan;33(1):190-234. doi: 10.1002/med.20252. Epub 2011 Sep 15. Med Res Rev. 2013. PMID: 21922503 Review.
-
Mode of action of anticancer peptides (ACPs) from amphibian origin.Anticancer Res. 2015 Feb;35(2):635-43. Anticancer Res. 2015. PMID: 25667440 Review.
-
Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.Colloids Surf B Biointerfaces. 2022 Jan;209(Pt 2):112165. doi: 10.1016/j.colsurfb.2021.112165. Epub 2021 Oct 21. Colloids Surf B Biointerfaces. 2022. PMID: 34715505
-
Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.Acta Biomater. 2018 Oct 15;80:269-277. doi: 10.1016/j.actbio.2018.09.025. Epub 2018 Sep 19. Acta Biomater. 2018. PMID: 30240951
Cited by
-
The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents.Dis Model Mech. 2011 Sep;4(5):622-33. doi: 10.1242/dmm.007310. Epub 2011 Jul 4. Dis Model Mech. 2011. PMID: 21729875 Free PMC article.
-
Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions.Comput Struct Biotechnol J. 2015 Dec 7;14:49-57. doi: 10.1016/j.csbj.2015.11.005. eCollection 2016. Comput Struct Biotechnol J. 2015. PMID: 26862373 Free PMC article.
-
Bioactive peptides for anticancer therapies.Biomater Transl. 2023 Mar 28;4(1):5-17. doi: 10.12336/biomatertransl.2023.01.003. eCollection 2023. Biomater Transl. 2023. PMID: 37206303 Free PMC article. Review.
-
Short Fragmented Peptides from Pardachirus Marmoratus Exhibit Stronger Anticancer Activities in In Silico Residue Replacement and Analyses.Curr Drug Discov Technol. 2024;21(6):e220224227304. doi: 10.2174/0115701638290855240207114727. Curr Drug Discov Technol. 2024. PMID: 38409702
-
In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide.Mol Ther Oncolytics. 2019 Dec 10;16:7-19. doi: 10.1016/j.omto.2019.12.001. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2019. PMID: 31909181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources